How to Control Content Uniformity in ODFs: From Coating to Inline Monitoring
Share
Introduction
Content uniformity is often the most overlooked — yet most critical — parameter in oral dissolvable film (ODF) manufacturing. For pharmaceutical and nutraceutical applications (including “Blue Hat” registration in China), non-uniform dosage can disqualify a product from even entering regulatory review. As ODF formulations become more complex, manual quality control methods are no longer sufficient to guarantee dose consistency.
1. Why Is Dose Uniformity So Difficult in ODFs?
With a typical film thickness of only 0.1–0.3 mm and active ingredients often in trace amounts, even small inconsistencies can lead to major dosage deviations. Key issues include:
- Minor coating irregularities (wrinkles, bumps, etc.) cause localized concentration errors.
- API migration or sedimentation during coating or drying phases.
- Manual sampling can miss edge zones or underrepresented sections.
2. Three Process Strategies for Better Content Uniformity
To ensure consistent content across the film surface, manufacturers should implement:
- Precision coating control with ±0.02 mm thickness tolerance and closed-loop liquid feeding systems.
- Inline thickness monitoring and AI-powered vision inspection to detect anomalies in real time.
- Full parameter logging including temperature, airflow, coating speed, and tension — enabling root-cause analysis.
3. HUANGHAI’s Integrated Equipment Solutions
At HUANGHAI, our ODF production systems are built for full-process control:
- Precision slot-die heads paired with automatic tension control.
- Optional inline thickness measurement with alarm/auto-stop functions.
- Exportable production data for audits and regulatory submission.
- Integration with content uniformity testers to enable real-time process feedback.
Explore our equipment here:
➤ MJ150-L ODF Film Coating Machine
➤ MJ150 ODF Production Line
➤ Pharmaceutical Testing Instruments
Conclusion
Content uniformity is a common — but solvable — challenge in the ODF industry. Choosing equipment with closed-loop control across coating and inspection processes is the key to achieving high-quality, compliant products that pass audits and reduce batch rejection rates.
*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.
Frequently Asked Questions
Q: What is the difference between an ODF film and a transdermal patch?
A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.
Q: What production output can I expect from a Huanghai ODF machine?
A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.
Q: What drying technology does Huanghai use for ODF production?
A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.
Q: What are the GMP requirements for ODF production equipment?
A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.
Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?
A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.
For details on our IQ/OQ/PQ certification suite and FDA compliance credentials, see our Certifications & Compliance page.
Explore Complete ODF & TDDS Manufacturing Solutions
Huanghai offers end-to-end ODF film production lines — from lab-scale R&D (BY-300A / MJ150-L) to commercial manufacturing (MJ150). GMP-certified and 21 CFR Part 11 compliant.